Paid Clinical Trials in Richmond, VA
As of June 2026, 648 paid clinical trials are recruiting in Richmond, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Richmond offers studies at sites including Virginia Commonwealth University for conditions such as Breast Cancer, Heart Failure, Acute Myeloid Leukemia, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Richmond
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Richmond
Richmond has approximately 648 recruiting research studies across a wide range of therapeutic areas. Virginia hosts the University of Virginia Health System, VCU Health, and Inova Health System, running clinical trials across oncology, cardiology, and neuroscience.
Top Research Study Locations in Richmond
Researchers run research studies in Richmond, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Commonwealth University | Heart Failure, Violence, Atrial Fibrillation | 167 |
| VCU Massey Comprehensive Cancer Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage IV Breast Cancer AJCC v8 | 121 |
| VCU Massey Cancer Center at Stony Point | Anatomic Stage II Breast Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 62 |
| Virginia Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Lung Non-Small Cell Carcinoma | 26 |
| Bon Secours Saint Mary's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Breast Cancer | 25 |
| Bon Secours Cancer Institute at Reynolds Crossing | Stage IVA Prostate Cancer AJCC v8, Breast Cancer, Stage III Prostate Cancer AJCC v8 | 23 |
| Bon Secours Richmond Community Hospital | Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 14 |
| Clinical Research Partners, LLC | Asthma, Celiac Disease, Clostridioides Difficile Associated Disease | 11 |
| VCU Medical Center | Intracerebral Hemorrhage, Acute Decompensated Heart Failure, Atrial Fibrillation | 11 |
| Virginia Commonwealth University Massey Cancer Center | B-cell Malignancy, Breast Cancer, Cardiovascular Complications | 11 |
| Hunter Holmes McGuire VA Medical Center, Richmond, VA | Acute Kidney Injury, Atherosclerosis, Cardiovascular Disease | 9 |
| Richmond VA Medical Center | Colorectal Neoplasms, Cardiovascular Diseases, Dementia Alzheimer Type | 9 |
| Virginia Commonwealth University Medical Center | Adolescent - Emotional Problem, Bipolar Disorder, Bipolar I Disorder | 9 |
| Virginia Commonwealth University/Massey Cancer Center | Non-Hodgkin Lymphoma, Stage IVB Prostate Cancer AJCC v8, Breast Carcinoma | 8 |
| Children's Hospital of Richmond at VCU | Focal Segmental Glomerulosclerosis, Acute Respiratory Distress Syndrome, Cardiac Arrest | 7 |
| Richmond VA Medical Center, Richmond, VA | Alcohol Use Disorder (AUD), Cirrhosis, Diabetic Foot | 6 |
| GSK Investigational Site | Chickenpox, Colonic Neoplasms, Liver Diseases, Alcoholic | 5 |
| Henrico Doctor's Hospital | Recurrent Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 5 |
| Virginia Commonwealth University (VCU) | Aortic Aneurysm, Abdominal, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 5 |
| Virginia Commonwealth University Health System | Acute Myocardial Infarction (AMI), COPD, Cardiovascular Risk | 5 |
| Chippenham Hospital | Atrial Fibrillation, Hypertension, Lumbar Spinal Stenosis | 4 |
| Dominion Medical Associates, Inc. | Aggression, Agitation,Psychomotor, Alzheimer Disease | 4 |
| Hunter Holmes McGuire VA Medical Center | Cirrhosis, Alcohol Use Disorder, Hepatic Encephalopathy | 4 |
| OvationLab | Biofilm, Biological Aging, Detoxification | 4 |
| Virginia Commonwealth University School of Medicine | Arrhythmia, Cardiomyopathies, Death, Sudden, Cardiac | 4 |
Active & Upcoming Studies in Richmond (2026)
Recruiting trials in Richmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (236 active studies)
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · Virginia Commonwealth University
- Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · Virginia Commonwealth University
Cardiovascular (54 active studies)
- A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler · Virginia Commonwealth University
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (25 active studies)
- A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler · Virginia Commonwealth University
- mHealth Intervention for Pain Self Management · Virginia Commonwealth University
Diabetes & metabolic (22 active studies)
- A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler · Virginia Commonwealth University
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities · Phase 2 · Verdiva Bio Dev Limited
Mental health & behavior (16 active studies)
- My Path to Quit Tobacco · Phase 4 · University of Wisconsin, Madison
- Enhancing Addiction Treatment Through Psychoeducation · Virginia Commonwealth University
Pediatric (7 active studies)
- Children's Bipolar Network Treatment Trial I · University of California, Los Angeles
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS · Phase 2, Phase 3 · Nationwide Children's Hospital
Vaccines (5 active studies)
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
HIV / STI (4 active studies)
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV · Phase 2 · Naga P. Chalasani
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
Eye & vision (4 active studies)
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD · Phase 3 · AbbVie
Common conditions studied in Richmond
- Breast Cancer (14 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (13 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Acute Myeloid Leukemia (9 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Obesity (9 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Malignant Solid Neoplasm (8 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (6 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Richmond
- Virginia Commonwealth University
- National Cancer Institute (NCI)
- AstraZeneca
- NRG Oncology
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in Virginia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Virginia research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Richmond. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Richmond
Hipa.ai aggregates every recruiting study in Richmond from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Richmond?
There are approximately 648 recruiting clinical trials in Richmond, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Richmond pay participants?
Most recruiting trials in Richmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Richmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Richmond?
The most common conditions under active study in Richmond include Breast Cancer (14), Heart Failure (13), Acute Myeloid Leukemia (9), Obesity (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Richmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Richmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Richmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Richmond?
Recruiting research sites in Richmond include Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, VCU Massey Cancer Center at Stony Point, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Richmond right now?
The largest active categories in Richmond are Cancer & tumors (236), Cardiovascular (54), Neurology & pain (25). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.